Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Ronapreve CMI 29 Nov 2022
Ronapreve PI 29 Nov 2022
Nuelin-SR CMI 29 Nov 2022
Evoltra CMI 29 Nov 2022
Evoltra PI 29 Nov 2022

New products

Product name Type Date released
Pfizer Daptomycin PI 16 Nov 2022
Pfizer Daptomycin CMI 16 Nov 2022
DBL Dacarbazine CMI 03 Nov 2022
Recagon CMI 03 Nov 2022
Comirnaty Bivalent BA.1 CMI 31 Oct 2022